0:00
/
Transcript

YOUR MEDICINE CABINET IS A PROFIT CENTER

The benefits get the music. The side effects get the fine print. This is not an accident.

American TV viewers sit through roughly sixteen hours of prescription drug advertising every single year. That’s not a typo. Sixteen hours. More time than most people spend at the movies. More than most people spend reading. And we are somehow surprised that we are one of the most over-medicated countries on the planet. Welcome to Uncomfortable.

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.


The Pitch

Here is how it works. You start with a condition. Something real, but vague enough to stretch. Difficulty focusing. Low energy. Social discomfort. Sadness. Restlessness. These are not invented experiences. They are human experiences. And that is exactly why they work as raw material.

You give the condition a name. Clinical weight. Generalized Anxiety Disorder. Restless Leg Syndrome. Social Phobia. Once it has a name, it has a diagnostic code. Once it has a diagnostic code, it has a reimbursable treatment. Once it has a reimbursable treatment, it has a commercial. And once it has a commercial — it has you.

The commercial runs sixty seconds. Fifteen of those seconds describe a world where you’re happier, lighter, more yourself. The other forty-five are a legal disclaimer read at the speed of an auctioneer. The benefits get the music. The side effects get the fine print.

This is not an accident. This is engineering. Every frame of that ad was tested, re-cut, and optimized. The soft lighting, the golden retriever, the couple laughing at a farmers market — every one of those choices was the product of focus groups and behavioral research. The disclaimer is read fast because the law requires it to be read, not because anyone wants you to hear it.

2×The pharmaceutical industry spends approximately twice as much on marketing as it does on research and development. The product isn’t the pill. You are.

Thanks for reading! This post is public so feel free to share it.

Share


The Science They Own

The pharmaceutical industry has been caught bribing physicians. Buying clinical trials. Burying research that showed their products caused harm. Many of the peer-reviewed studies published in major medical journals were ghost-written by the drug companies themselves. Doctors took payments and allowed their names to appear as the authors. This isn’t speculation. They got caught. In court. On the record. Under oath.

The company behind Vioxx buried evidence of cardiovascular risk. The estimates of how many people died as a result range from twenty-seven thousand to fifty thousand — with one senior FDA official putting it at the higher end. Fifty thousand people. Of those cases, eighteen reached a jury. Eighteen. The rest of the plaintiffs will likely be dead before anyone compensates them for anything.

THAT IS NOT A ROGUE ACTOR.
THAT IS A SYSTEM.

The tobacco industry denied the health effects of their products for decades. They promoted “independent research” they were financing. They marketed to children. They poured hundreds of millions into lobbying to own Congress. They suppressed evidence that their products killed people. When we finally held them accountable, it felt like a turning point. It wasn’t.

The pharmaceutical industry watched that entire catastrophe play out — and then ran the same play wearing a white coat. The only meaningful difference is that while the FDA was openly hostile toward tobacco, toward the pharmaceutical industry, it rolls over.

You both deny the damaging health effects of your products. You both promote so-called “independent research” which you actually finance. You both market to children. You both pour millions into lobbying efforts to buy Congress. You both suppress information that proves your products kill people. The only difference is that the FDA was hostile toward cigarettes. Toward pharma, it rolls over.


The Customer Acquisition Strategy

The oldest move in consumer marketing: get them young and keep them. The pharmaceutical industry understands this better than almost anyone else in business. We now have three-year-olds on antidepressants. Not because three-year-olds developed a sudden clinical need for antidepressants. Because if you can establish the treatment early enough, you have a customer for the next seventy years.

Big Tobacco figured this out decades ago. Find the youngest possible entry point, normalize the product, and the lifetime value of the customer does the rest of the math for you. Pharma watched that model get demolished in court and decided to run the same play under a more defensible label. Medication sounds different than cigarettes. It isn’t.

650KPeople released from incarceration every year in the U.S. Two-thirds re-offend and return. That’s a national failure. For the private prison industry, it’s a stable revenue model. The pharmaceutical industry’s recidivism equivalent is relapse, dependence, and chronic condition management. They call it “long-term care.” It’s called recurring revenue.


What “Industry Standards” Actually Means

The defense the industry always runs is the same defense every industry runs when they’ve been caught doing exactly what they were designed to do. Rogue employee. Unforeseeable. We followed industry standards. We screened everyone. No prior history. How could anyone have known?

Here’s how. You could have required independent trial replication before approval. You could have mandated that ghost-writing be disclosed. You could have held physicians accountable for the payments they accepted. You could have funded the FDA adequately enough to do its actual job. You could have made the side effects as legible as the benefits.

“Industry standards” is the phrase an industry uses when it wants credit for doing the minimum. It means: we did exactly what every other company that has also been sued for this exact thing does. It is a cartel’s definition of acceptable behavior, offered to a regulator too compromised to reject it.

You cannot market yourself as above the bar and then argue the bar is low enough to clear when someone gets hurt. You don’t get both. Either you’re exceptional, or you’re hiding behind the herd. Pick one. The industry has been picking both for forty years, and historically, nobody has been paying close enough attention to make them choose.

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.


Senior Citizens Are the Target Market

There is a reason pharmaceutical advertising is concentrated on certain networks at certain hours. There is a reason the actors in those commercials are overwhelmingly in their fifties, sixties, seventies. The industry’s own internal research shows that older Americans are highly susceptible to this kind of advertising — not because they’re less intelligent, but because they’re in the stage of life where the fear being sold is most credible. The fear of losing function. The fear of pain. The fear of death.

A man takes forty-two different drugs because he’s seen forty-two different commercials promising that forty-two different conditions he might have can be addressed by a pill. He ends up in a hospital. Nearly dead. And the industry’s response is: that was his own fault. He made autonomous choices. Nobody made him take those drugs.

They wouldn’t advertise it if it wasn’t safe. That is the working assumption of millions of Americans. And the industry built that assumption deliberately, expensively, and over decades. You don’t get to create the delusion and then disclaim responsibility for the people living inside it.


The Regulatory Capture

The FDA is supposed to be the check on all of this. It isn’t. The pharmaceutical lobby has a stranglehold on Congress. The regulatory apparatus that exists to protect the public has been systematically underfunded, influenced, and in some cases staffed by the industry it is supposed to regulate. When products kill people, it takes years to get them off the market. When evidence of harm is suppressed, the criminal exposure is minimal. When companies pay billion-dollar settlements, they keep the profits that justified the original decision.

If the penalty for poisoning people is a percentage of what you made by poisoning them, that is not a penalty. That is a licensing fee.

THE PENALTY FOR POISONING PEOPLE
IS A PERCENTAGE OF WHAT YOU MADE.
THAT ISN’T JUSTICE.
THAT’S A LICENSING FEE.


Go Look at the Ads

Go look at the ads. Every one of them is engineered the same way. A beautiful life you don’t currently have. A named condition that might explain the gap. A drug that bridges it. A phone number, a website, and forty-five seconds of side effects that include, occasionally, death. Ask your doctor.

Millions of Americans are being diagnosed with vague disorders, prescribed habit-forming drugs, and told this is medicine. Some of it is. A lot of it is a business model wearing a white coat. The distinction matters. The industry spends twice as much making sure you don’t examine that distinction as it does on the science underlying it.

Nobody is saying every drug is a scam, every diagnosis is invented, or every pharmaceutical company is evil. What is being said — what the evidence demands be said — is that an industry with a documented history of concealing harm, bribing researchers, manufacturing diagnoses, and marketing dependence to the most vulnerable people in society does not deserve the benefit of the doubt it has been given and continues to receive.

The music stops. The disclaimer starts. Somewhere in that fine print, between the golden retriever and the auctioneer, is the actual story.


And Finally…

Nobody is coming to do this for you. The FDA won’t go after them. Congress won’t go after them. The same lobbying money that writes the bills also funds the campaigns of the people who are supposed to investigate the people writing the bills. That’s not a conspiracy theory. It’s a budgetary line item you can look up.

So let it be somebody else. Let it be you. Ask the questions. Read past the commercial. Demand that the side effects get the same production value as the benefits.

Because the music stops eventually. And then the disclaimer starts. And you deserve to hear it at the same volume.

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.


■ Eight Lines Worth Stealing

The benefits get the music. The side effects get the fine print. This is not an accident. #Uncomfortable — uncomfortable.rxansmithmedia.com

They wouldn’t advertise it if it wasn’t safe. The industry built that assumption deliberately, expensively, and over decades. You don’t get to create the delusion and then disclaim the people living inside it. #Uncomfortable — uncomfortable.rxansmithmedia.com

“Industry standards” is what an industry says when it wants credit for doing the minimum. #Uncomfortable — uncomfortable.rxansmithmedia.com

If the penalty for poisoning people is a percentage of what you made by poisoning them, that is not a penalty. That is a licensing fee. #Uncomfortable — rxansmithmedia.com

Big Tobacco watched that model get demolished in court — and pharma ran the same play wearing a white coat. #Uncomfortable — rxansmithmedia.com

The FDA was hostile toward cigarettes. Toward the pharmaceutical industry, it rolls over. #Uncomfortable — uncomfortable.rxansmithmedia.com

They have a documented history of concealing harm, bribing researchers, manufacturing diagnoses, and marketing dependence to the most vulnerable people in society. That industry does not deserve the benefit of the doubt it continues to receive. #Uncomfortable — uncomfortable.rxansmithmedia.com

The music stops. The disclaimer starts. You deserve to hear it at the same volume. #Uncomfortable — uncomfortable.rxansmithmedia.com

UNCOMFORTABLE

uncomfortable.rxansmithmedia.com

Discussion about this video

User's avatar

Ready for more?